22 February 2021 - AstraZeneca today announced the voluntary withdrawal of the Imfinzi (durvalumab) indication in the US for previously treated ...
27 October 2020 - At Health Canada's request, Leo Pharma is withdrawing Picato from the Canadian market. ...
16 October 2020 - Agios continues to advance two Phase 3 combination trials of Tibsovo in newly diagnosed AML patients. ...
5 October 2020 - Today, the U.S. FDA’s Center for Drug Evaluation and Research proposed that Makena (hydroxyprogesterone caproate injection) ...
30 September 2020 - Allergan is working closely with Health Canada to voluntarily withdraw Fibristal (ulipristal acetate 5 mg tablets) ...
13 February 2020 - Potential risk of cancer outweighs the benefits. ...
31 January 2020 - Company committed to first-line lung cancer patients in Europe, U.S. and other markets with planned filing of ...
15 January 2020 - Nektar Therapeutics issued a statement today following a meeting of the FDA's Anesthetic and Analgesic Drug ...
26 April 2019 - EMA has completed its assessment of the results of the ANNOUNCE study and concluded that Lartruvo ...
25 April 2019 - Lilly is working to ensure current patients access to Lartruvo with limited interruption after it is ...
15 March 2018 - Consumers and health professionals are advised that Biogen Australia, in consultation with the TGA, will withdraw ...
7 March 2018 - Evidence indicates risk of serious inflammatory brain disorders. ...
2 March 2018 - Patient safety is the top priority for Biogen and AbbVie. ...
16 August 2017 - Biocon has withdrawn its application seeking European Union approval for two drugs after the EU drugs ...
7 July 2017 - In the end, the executive team at Endo International blinked. ...